Skip to main content

Rosacea Content

FDA Alerts
The FDA has approved a new topical foam medication for the treatment of inflammatory lesions caused by rosacea in adults.
NRS Approved Features, Partners
Lauren Mateja, Managing Editor
The number of therapeutic options for rosacea management has expanded, but these treatments can only help patients who have been diagnosed. Rosacea Awareness Month seeks to help identify patients who may otherwise ignore their warning signs.
NRS Approved Features, Partners
Melissa Weiss, Associate Editor
It is no secret that rosacea can cause significant stress on patients and affect quality of life. The Dermatologist spoke with Linda Stein Gold, MD, about the current best practices for treating rosacea, as well as new therapies under investigation that may help patients achieve clear skin.
News
Researchers investigated the efficacy of 1% minocycline gel and 3% minocycline gel compared with vehicle for achieving treatment success among participants with papulopustular rosacea.
NRS Approved Features
Kara Rosania, Senior Editorial Director
Persistent facial erythema can affect quality of life for patients with rosacea. A new booklet with a handy redness register can help patients gauge their facial redness before and after a flare-up.
NRS Approved Features, Partners
Jill Waldbieser, Managing Editor
Although rosacea affects patients with skin of color at lower rates, those incidences may be underreported. To change that, dermatologists need to improve diagnostic accuracy for these patients.
NRS Approved Features, Partners
Jill Waldbieser, Managing Editor
A leading expert on how food affects skin weighs in on dietary triggers and ways to manage them.
News
Results from a recent study showed a combination of ivermectin and doxycycline effectively improved rosacea, including ocular symptoms, with some participants seeing results as early as 4 weeks.
NRS Approved Features
Mary Erhard, National Rosacea Society
The psychological burden of rosacea—as well as signs and symptoms—may be resolved with a dermatologist’s help.
NRS Approved Features
Maureen Ezekor, BBA, and Steven Feldman, MD, PhD—Chief Medical Editor
While certain cancers may be more common in patients with rosacea than in the general population, this increased risk is of questionable significance.
Back to Top